Piramal Enterprises Limited

Piramal Enterprises Limited, a pharmaceutical preparation manufacturing company headquartered in India, reported its most recent emissions data for 2025. In that year, the company's Scope 1 emissions were 91,960 kg CO2e, and its Scope 2 emissions were 5,843,390 kg CO2e. This follows 2024, where Scope 1 emissions were 24,300 kg CO2e and Scope 2 emissions were 5,535,220 kg CO2e.

For the year 2023, Piramal Enterprises Limited reported a total of approximately 581.3 million kg CO2e. This included Scope 1 emissions of 55,229,000 kg CO2e, Scope 2 emissions of 75,494,000 kg CO2e, and Scope 3 emissions of 450,639,000 kg CO2e. In 2022, the company's total emissions were approximately 619.8 million kg CO2e, comprising Scope 1 emissions of 56,578,000 kg CO2e, Scope 2 emissions of 85,844,000 kg CO2e, and Scope 3 emissions of 477,407,000 kg CO2e.

In 2021, Piramal Enterprises Limited's Scope 1 emissions were 63,950,000 kg CO2e and Scope 2 emissions were 101,583,000 kg CO2e. For 2020, Scope 1 emissions were 40,881,000 kg CO2e and Scope 2 emissions were 86,928,000 kg CO2e. No emissions data is available for 2019.

Piramal Enterprises Limited has not publicly disclosed any specific document-based or SBTi reduction targets, nor is it a signatory to The Climate Pledge.